This anti-tumor effect was also induced by treating the mice with Pramlintide, an FDA-approved synthetic analogue of amylin that is used to treat type 1 and 2 diabetes in conjunction with insulin [26,27]. This evidence concerns the gene IAPP and neoplasm.